D. Bollens

Most-cited papers

1. High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial.

   Y. Yazdanpanah, C. Fagard, D. Descamps, A. Taburet +9 more

   2009Clinical Infectious Diseases244 citations Open access

   Semantic Scholar

   Save

2. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.

   M. Meyohas, P. Roux, D. Bollens, C. Chouaid +5 more

   1995Clinical Infectious Diseases127 citations

   Semantic Scholar

   Save

3. Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study.

   B. Charbit, A. Rosier, D. Bollens, F. Boccara +4 more

   2009British Journal of Clinical Pharmacology50 citations Open access

   Semantic Scholar

   Save

4. Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

   C. Goujard, I. Vincent, J. Meynard, Nathalie Choudet +6 more

   2003Antimicrobial Agents and Chemotherapy35 citations Open access

   Semantic Scholar

   Save

5. Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients.

   M. Valantin, R. Bittar, P. de Truchis, D. Bollens +7 more

   2010Journal of Antimicrobial Chemotherapy32 citations

   Semantic Scholar

   Save

6. Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature

   C. Skayem, Majda Askour, C. Gary, F. Hemery +21 more

   2023Acta Dermato-Venereologica26 citations Open access

   Semantic Scholar

   Save

7. Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection

   N. Bhatnagar, P. Girard, Moises Lopez-Gonzalez, C. Didier +7 more

   2017Frontiers in Immunology22 citations Open access

   Semantic Scholar

   Save

8. Long-Term Outcome and Treatment Modifications in a Prospective Cohort of Human Immunodeficiency Virus Type 1-Infected Patients on Triple-Drug Antiretroviral Regimens

   P. Girard, M. Guiguet, D. Bollens, I. Goderel +6 more

   200018 citations Open access

   Semantic Scholar

   Save

9. γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activation.

   Mathieu F. Chevalier, N. Bhatnagar, C. Didier, Moises Lopez-Gonzalez +8 more

   2019AIDS (London)12 citations

   Semantic Scholar

   Save

10. Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient.

    J. Pacanowski, D. Bollens, J. Poirier, L. Morand-Joubert +3 more

    2009AIDS (London)10 citations Open access

    Semantic Scholar

    Save

11. Treatment of non-meningeal cryptococcosis in patients with AIDS. Centre d'Informations et de Soins de l'Immunodéficience Humaine de l'Est Parisien.

    M. Meyohas, J. Meynard, D. Bollens, P. Roux +5 more

    1996Journal of Infection8 citations

    Semantic Scholar

    Save

12. How to improve the quality of a disease management program for HIV-infected patients using a computerized data system. The Saint-Antoine Orchestra program

    L. Fonquernie, K. Lacombe, J. Vincensini, F. Boccara +8 more

    2010AIDS Care7 citations

    Semantic Scholar

    Save

13. Major Hypertriglyceridemia in HIV-Infected Patients on Antiretroviral Therapy: A Role of the Personal and Family History

    D. Bollens, M. Guiguet, P. Tangre, L. Rollinat +5 more

    2004Infection4 citations

    Semantic Scholar

    Save

14. Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators.

    P. Girard, M. Guiguet, D. Bollens, I. Goderel +6 more

    2000Clinical Infectious Diseases4 citations

    Semantic Scholar

    Save

15. [Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection].

    J. Meynard, M. Guiguet, A. Rachline, N. Boukli +4 more

    2001Presse medicale3 citations

    Semantic Scholar

    Save

16. [Early diagnosis and prevention of comorbidities among HIV-infected patients: the Orchestra Saint-Antoine Program].

    L. Fonquernie, S. Clozel, J. Vincensini, F. Boccara +9 more

    2007Médecine et maladies infectieuses2 citations

    Semantic Scholar

    Save

17. Preservation of IL-17 producing γδ T cells and their role in the control of immune activation in HIV controllers: ANRS EP56 study

    L. Weiss, N. Bhatnagar, D. Scott-Algara, C. Duvivier +6 more

    20170 citations Open access

    Semantic Scholar

    Save

18. P.406 Weak and delayed hepatitis C virus-specific T cell responses during acute hepatitis C in HIV-infected patients

    A. Schnuriger, S. Dominguez, M. Valantin, R. Tubiana +8 more

    20060 citations

    Semantic Scholar

    Save

19. P.408 Safety and efficacy of a 24-week course of pegylated interferon α-2a and ribavirin for the treatment of acute HCV infection in HIV positive patients

    S. Dominguez, J. Ghosn, A. Schruniger, M. Valantin +8 more

    20060 citations

    Semantic Scholar

    Save

20. Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

    C. Goujard, I. Vincent, J. Meynard, Nathalie Choudet +6 more

    20020 citations

    Semantic Scholar

    Save

21. Sustained plasma TG-lowering may be obtained with fish oil, in HIV+ patients who develop hyperlipidemia under highly active antiretroviral therapy

    M. Kirstetter, D. Bollens, F. Leconte-Veyriac, S. Blais-Leroy +2 more

    20000 citations

    Semantic Scholar

    Save